Evogene
EVGN
18 hedge funds and large institutions have $15.2M invested in Evogene in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.
0.45% less ownership
Funds ownership: 3.37% → 2.92% (-0.45%)
14% less funds holding
Funds holding: 21 → 18 (-3)
27% less capital invested
Capital invested by funds: $20.8M → $15.2M (-$5.64M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$513K |
| 2 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$118K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$71.5K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$46.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.31M |
| 2 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$466K |
| 3 |
MCM
Moon Capital Management
New York
|
-$251K |
| 4 |
JP Morgan Chase
New York
|
-$228K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$155K |
EVGN Hedge Fund Activity: Q2 2019 in Review
18 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q2 2019, worth a combined $15.2M — down 27% from $20.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EVGN and 1 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was Senvest Management, adding an estimated $513K. The largest seller was Bank of America, cutting an estimated $1.31M.
- 18 institutional investors held Evogene (EVGN) as of Q2 2019, down from 21 in Q1 2019.
- Funds reported $15.2M of Evogene stock for Q2 2019, down 27% quarter-over-quarter.
- 1 fund opened new Evogene positions in Q2 2019 and 4 closed out, a net change of -3 holders.
- The largest Evogene buyer in Q2 2019 was Senvest Management, an estimated $513K added.
- The largest Evogene seller in Q2 2019 was Bank of America, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2019.